AbbVie
ABBV
#25
Rank
โ‚น31.361 T
Marketcap
โ‚น17,729
Share price
1.07%
Change (1 day)
17.62%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

Earnings for AbbVie (ABBV)

Earnings in 2024 (TTM): โ‚น305.05 Billion

According to AbbVie's latest financial reports the company's current earnings are โ‚น56.33 Billion. a decrease over its 2023 earnings that were of โ‚น534.02 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for AbbVie from 2011 to 2024

Annual earnings

Year Earnings Change
2024 โ‚น317.50 B-40.54%
2023 โ‚น534.02 B-53.62%
2022 โ‚น1.151 T3.76%
2021 โ‚น1.109 T282.25%
2020 โ‚น290.33 B-59.67%
2019 โ‚น719.95 B62.13%
2018 โ‚น444.05 B-32.74%
2017 โ‚น660.22 B-1.99%
2016 โ‚น673.64 B18.65%
2015 โ‚น567.77 B180.5%
2014 โ‚น202.41 B-55.57%
2013 โ‚น455.58 B-6.86%
2012 โ‚น489.15 B56.05%
2011 โ‚น313.45 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
โ‚น949.53 B 199.06%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น715.94 Billion-325.48%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น1.083 T 241.24%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น393.81 B 24.03%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น58.95 B-81.43%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น162.85 B-48.71%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น375.48 B 18.26%๐Ÿ‡ฌ๐Ÿ‡ง UK
โ‚น891.43 B 180.76%๐Ÿ‡ฌ๐Ÿ‡ง UK
โ‚น43.85 B-86.19%๐Ÿ‡บ๐Ÿ‡ธ USA